Atopic Dermatitis

News Atopic Dermatitis

• Ectoine: a natural compound reduces lung inflammation

  Scientists from the IUF Leibniz Research Institute for Environmental Medicine in Düsseldorf show that the extremolyte Ectoin® may positively influence lung inflammation associated with chronic obstructive pulmonary disease (COPD). From earlier studies it was known that Ectoin has the potential to pr more

• Creabilis Raises €15M in Series B Fundraising Round

  Creabilis SA has raised €15 million ($20 million) in a Series B funding round led by Abbott Biotech Ventures. Existing investors Neomed and Sofinnova Partners, as well as private Italian investors, joined the round. The new funds will be used to finance the development of the company’s first-in-clas more

• Novartis sells global rights to Elidel, a medicine to treat atopic dermatitis

  Novartis announced that it has signed an agreement to sell to Meda the global rights to manufacture, market and commercialize Elidel® (pimecrolimus) Cream 1%, a medicine to treat mild to moderate atopic dermatitis. This agreement reflects Novartis strategy to focus commercialization on new launch po more

Publications Atopic Dermatitis

• Genome-Wide Analysis in German Shepherd Dogs Reveals Association of a Locus on CFA 27 with Atopic Dermatitis

  by Katarina Tengvall, Marcin Kierczak, Kerstin Bergvall, Mia Olsson, Marcel Frankowiack, Fabiana H. G. Farias, Gerli Pielberg, Örjan Carlborg, Tosso Leeb, Göran Andersson, Lennart Hammarström, Åke Hedhammar, Kerstin Lindblad-Toh Humans and dogs are both affected by the allergic skin disease atopi more

• An assessment of the genetic toxicology of novel boron‐containing therapeutic agents

  Boron‐containing compounds are being studied as potential therapeutic agents. As part of the safety assessment of these therapeutic agents, a battery of genetic toxicology studies was conducted. The battery included a bacterial reverse mutation (Ames) assay, an in vitro chromosome aberration assay more

• Atopic dermatitis‐mitigating effects of new Lactobacillus strain, Lact. sakei probio 65 isolated from Kimchi

  Abstract Aims Atopic dermatitis (AD) is a inflammatory skin disease. Probiotics have been reported to modulate immune responses, and thus are now being suggested as potential treatments for allergies. In this study, we investigated the inhibitory effects of Lactobacillus sakei probio 65 isolat more

Market studies Atopic Dermatitis

• Atopic Dermatitis (Eczema) Global Clinical Trials Review, H1, 2012

  Introduction GlobalData's clinical trial report, “Atopic Dermatitis (Eczema) Global Clinical Trials Review, H1, 2012" provides data on the Atopic Dermatitis (Eczema) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atopic Dermatitis (E more

• Atopic Dermatitis (Eczema) – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Atopic Dermatitis (Eczema) - Pipeline Review, H2 2012', provides an overview of the Atopic Dermatitis (Eczema) therapeutic pipeline. This report provides information on the therapeutic development for Atopic Dermatitis (Eczema), complete with latest updates, more

• Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline

  GBI Research, the leading business intelligence provider, has released its latest research, “Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline”. It provides in-depth analysis of the unmet needs, drivers and more

Websites Atopic Dermatitis